See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Social Media
Baseball
Donald Trump
South America
Natural Disasters
Tariffs
Trade War
Formula 1
Artificial Intelligence
Catholic Church
Real Madrid
Immigration
Published • loading... • Updated

Teva Pharmaceutical Industries (NYSE:TEVA) Downgraded to Hold Rating by StockNews.com

Summary by marketbeat.com
StockNews.com lowered Teva Pharmaceutical Industries from a "buy" rating to a "hold" rating in a research note on Monday.

2 Articles

All
Left
Center
1
Right
marketbeat.commarketbeat.com
Center

Teva Pharmaceutical Industries (NYSE:TEVA) Downgraded to Hold Rating by StockNews.com

StockNews.com lowered Teva Pharmaceutical Industries from a "buy" rating to a "hold" rating in a research note on Monday.

Read Full Article
americanbankingnews.comamericanbankingnews.com

StockNews.com Downgrades Teva Pharmaceutical Industries (NYSE:TEVA) to Hold

Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Monday. A number of other analysts also recently issued reports on the company. UBS Group cut their target price on Teva Pharmaceutical Industries from $30.00 […]

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

americanbankingnews.com broke the news in on Wednesday, April 16, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Petah Tikva

Petah Tikva

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal